Tilray Brands (TLRY) Other Operating Expenses (2019 - 2026)
Tilray Brands (TLRY) posted Other Operating Expenses of $118000.0 for Q1 2026, down 11.94% on a QoQ basis from $134000.0 in Q4 2025, and down 41.58% year-over-year from $202000.0 in Q1 2025.
Tilray Brands (TLRY) Other Operating Expenses (2019 - 2026) Analysis & Trends
Tilray Brands' Other Operating Expenses history runs 8 years deep, the most recent figure standing at $118000.0 for Q1 2026.
- Quarterly Other Operating Expenses fell 41.58% year-over-year to $118000.0 in Q1 2026, while the trailing twelve-month figure through Feb 2026 was $13.6 million (up 176.92% YoY) and the FY2025 annual result came in at -$928000.0, down 122.11% from the prior year.
- Other Operating Expenses was $118000.0 for Q1 2026 at Tilray Brands, down from $134000.0 in the prior quarter.
- Across five years, Other Operating Expenses topped out at $15.0 million in Q3 2025 and bottomed at -$1.7 million in Q2 2025.
- A 5-year average of $1.2 million and a median of $57500.0 in 2022 frame the typical range for Other Operating Expenses.
- Peak annual rise in Other Operating Expenses reached 9032.61% in 2024, while the deepest fall reached 253.33% in 2024.
- Tilray Brands' Other Operating Expenses stood at $64000.0 in 2022, then sank by 64.06% to $23000.0 in 2023, then surged by 2095.65% to $505000.0 in 2024, then plunged by 73.47% to $134000.0 in 2025, then slipped by 11.94% to $118000.0 in 2026.
- Business Quant data shows TLRY's Other Operating Expenses at $118000.0 in Q1 2026, $134000.0 in Q4 2025, and $15.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Tilray Brands | 465.02 Mn | 373.06 Mn | 54.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 118,000.00 |
| Nov 30, 2025 | 134,000.00 |
| Aug 31, 2025 | 15.00 Mn |
| May 31, 2025 | -1.66 Mn |
| Feb 28, 2025 | 202,000.00 |
| Nov 30, 2024 | 505,000.00 |
| May 31, 2024 | 4.20 Mn |
| Feb 29, 2024 | -23,000.00 |
| Nov 30, 2023 | 23,000.00 |
| Aug 31, 2023 | -3,000.00 |
| May 31, 2023 | 46,000.00 |
| Feb 28, 2023 | 15,000.00 |
| Nov 30, 2022 | 64,000.00 |
| Aug 31, 2022 | -77,000.00 |
| May 31, 2022 | 51,000.00 |
| Feb 28, 2022 | 861,000.00 |
| Nov 30, 2021 | 46.98 Mn |
| Aug 31, 2021 | 68.09 Mn |
| May 31, 2021 | 60.58 Mn |
| Feb 28, 2021 | 29.21 Mn |